An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer. - McAndrews KM; Paradiso F; Stalnecker CA; Chellakkan BS; Thege FI; Peng DH; Moreno Diaz BA; Sugimoto H; Patel SI; Mahadevan KK; Kirtley ML; Wills D; et al. (Science translational medicine, 2025)